Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5658 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 25 26 27 ... 55 56 57  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Analytik Jena–PERSON: investment, 201410 DIVESTMENT Klaus Berka to sell his shares to Endress+Hauser (Deutschland) GmbH & Co KG 2014-10-01
Analytik Jena–Thuringia (govt): investment, 201410 DIVESTMENT TIB to sell shares in AJ to Endress+ Hauser (Deutschland) AG & Co KG 2014-10-01
Bayer–Belchim Crop Protection: fungicide, 201410– acquisition sole European distribution rights €na for biofungicide Contans WG by Bayer CropScience 2014-10-01
Bayer–Univ Kyoto: drug discovery, 201410–201609 collab 2y to jointly identify drug candidates of KU-SACI + Bayer Open Innovation Center Japan 2014-10-01
Curasan–SEVERAL: investment, 201410 capital increase w subscription rights €1.5m 2014-10-01
Imevax–Germany (govt): grant, 201410 GO-Bio Phase II grant €5.9m from BMBF 2014-10-01
Merck (US)–Bayer: OTC drugs, 201410 acquisition $14.2b in cash of Merck’s consumer care business incl Claritin by Bayer 2014-10-01
Merck (US)–Bayer: sGC modulators, 201410– collab strategic alliance ww co-developm + co-commercialisation $1b upfront + $1.1b milestones 2014-10-01
Multi Channel Systems MCS–Harvard Bioscience: investment, 201410 acquisition €7.5m in cash by Harvard Bioscience 2014-10-01
SAW Instruments–NanoTemper: investment, 201410 acquisition by NanoTemper Technologies GmbH 2014-10-01
Singapore (govt)–Bruker Corp: imaging technology, 201410 collab establishment of joint SBIC-Bruker Preclinical Imaging (PCI) Center 2014-10-01
Life Sciences Partners–SEVERAL: investment, 201409 launch €80m LSP 5 fund with target size of €150m 2014-09-30
Metrohm–Ecknauer & Schoch: public relations, 201409 service existent 2014-09-29
Shimadzu–m/e Brand Communication: public relations, 201409 service existent 2014-09-29
Probiodrug–SEVERAL: investment, 201409–201410 IPO €23.2m at Euronext Amsterdam 2014-09-25
Fuchs Petrolub–BRAIN: lubricant, 201409– collab development of lubricants produced from renewable raw materials 2014-09-24
Molecular Partners–SEVERAL: investment, 201409–201412 IPO CHF106.2m at SIX Swiss Exchange 2014-09-23
Sigma-Aldrich–Merck (DE): investment, 201409–201511 acquisition $17b in cash 2014-09-22
Analytik Jena–Endress+Hauser: investment, 201409–201410 acquisition of addit 27.56% from Klaus Berka + TIB rasing share to 82.22% 2014-09-18
Boehringer–CureVac: RNActive vaccine, 20140901– collab developm + excl ww license for CV9202 €35m upfront + €430m milestones + royalties 2014-09-18
Cardiorentis–HealthCare Royalty Partners: financing, 201409 financing agreement €45m with undislosed features 2014-09-17
OSE Pharma–SEVERAL: investment, 201409–201503 IPO €21.1m at Euronext Paris 2014-09-17
Merck (DE)–Lupin: pharmaceuticals, 201409– strategic alliance €na developm + dossiers + supply by Lupin + marketing Merck Serono in emerging markets 2014-09-16
MorphoSys–Germany (govt): grant, 201409– BMBF grant up to €1m to develop Ylanthia antibodies against two undisclosed GPCR targets 2014-09-15
Nobel Biocare–Danaher: investment, 201409–201412 public cash tender offer CHF17/share w total value of $2.2b incl debt assumed + net of cash acquired 2014-09-15
SensoQuest–Eppendorf: thermal cycler, 201409– license covering gradient technology for thermal cyclers to SensoQuest GmbH 2014-09-15
Abbott–Biocartis: molecular diagnostics, 201409 collab existent development of diagnostic tests with Abbott Molecular 2014-09-12
Boehringer–Minapharm: rec protein production technology, 201409 license existent from ProBioGen 2014-09-09
Novartis–Minapharm: rec protein production technology, 201409 license existent from ProBioGen 2014-09-09
Vexim–LifeSci: public relations, 201409 service existent by LifeSci Advisors 2014-09-08
Zürcher Kantonalbank–Bellevue: investment, 201409– acquisition 100% of Adamant Biomedical Investments AG from ZKB 2014-09-05
Biocartis–SEVERAL: investment, 201409 financing round €64.5m from JnJ + Hitachi + PMV Tina Fund + family offices 2014-09-04
MyCartis–SEVERAL: investment, 201409 1st financing round €15m from RMM + Valiance + Biover II 2014-09-04
Pronota–Biocartis: investment, 201409 merger of Pronota with spun-out Swiss Evaluation business of Biocartis to form MyCartis 2014-09-04
4SC–Yorkville Group: credit, 201409 second tranche €500k convertible notes under up to €15m agreem from 2/14 w YA Global Master SPV Ltd 2014-09-03
Nabriva–Hume Brophy: public relations, 201409 service existent by Hume Brophy 2014-09-03
Affimed–Perceptive Advisors: credit, 201409– loan agreem over €10.5m 2014-09-02
Affimed–SEVERAL: investment, 201409 financing round Series E €11.7m led by existing investors 2014-09-02
BeiGene–Boehringer: biopharmaceuticals, 201409– strategic supply + manufacturing agreem for biopharmaceuticals using mammalian cell culture technology 2014-09-02
Merck (DE)–S-Target Therapeutics: S-TIR technology, 201409– license excl ww €na to Allergopharma to develop antiallergics 2014-09-02
Bayer–MetaSysX: metabolomic services, 201409–201708 supply services to Bayer CropScience to improve agricultural productivity 2014-09-01
Berlin Cures–Helmholtz: investment, 201409 Ascenion acquires shares at time of spin-off from Charité + MDC in return for services 2014-09-01
Berlin Cures–Minverva Partners: investment, 201409 seed investment at time of spin-off from Charité + MDC from Minerva Partners AG 2014-09-01
CHDI–Evotec: drug discovery services, 201409–201708 collab service extension CDHI funding up to 52 full-time scientists for Huntington’s disease drugs 2014-09-01
Corgenix Medical–Orgentec: investment, 201409–201503 acquisition of Corgenix for $16m in cash by Orgentec Diagnostika 2014-09-01
Ipsen–MHH: rec botulinum neurotoxin, 201409– collab r+d with Thomas Binz at Institute for Physiological Chemistry at MHH 2014-09-01
Univ Hamburg–Bruker Corp: MPI system, 201409 supply installation of 1st commercial MPI PreClinical system at UKE 2014-09-01
BASF–Cenix BioScience: biomarker discovery + validation, 201408– supply service €na research framework agreement with Metanomics Health 2014-08-26
Recipe–Tecan: automated liquid handling, 201408– collab co-marketing of ClinMass LC-MSMS Complete Kits with Freedom EVO platform 2014-08-26
Covagen–JnJ: investment, 201408 acquisition €na by Cilag GmbH International 2014-08-25
Eppendorf–Wallinger Ricker Schlotter Tostmann: legal services, 201408 Eppendorf is client of WRST with regard to gradient PCR patent litigation 2014-08-25
SensoQuest–Rehberg Hüppe: legal services, 201408 SensoQuest is client of RHP with regard to gradient PCR patent litigation 2014-08-25
InterMune–Roche: investment, 201408– acquisition $8.3b in cash 2014-08-24
Bruker Corp–F-DGSi: gas generator, 201408 supply + collab existent resale of F-DGSi gas generators by Bruker with Bruker instruments 2014-08-22
Gamida Cell–Novartis: investment, 201408 acquisiton 14% equity share for $35m by Novartis Pharma AG plus option to fully acquire Gamida Cell 2014-08-19
MorphoSys–Emergent BioSolutions: antibody cancer drug, 201408– collab developm + commercialisation rights or ES414 outside North America for MorphoSys 2014-08-19
Bruker Corp–CMS: legal services, 201408 service legal advice by CMS Hasche Sigle on acqu of Bruker’s ICP-MS business by Analytik Jena 2014-08-14
Lentigen–Miltenyi Biotec: investment, 201408 acquisition lentiviral manufacturing business + assets continuing as Miltenyi sub Lentigen Technology Inc 2014-08-14
Miltenyi Biotec–Scott Partnership: public relations, 201308 service existent by Phoenix MarCom 2014-08-14
Bruker Corp–Analytik Jena: investment, 201407–201409 acquisition €na of ICP-MS business from Bruker by AJ 2014-08-13
RayBiotech–Scienion: print/spotting technology, 201408– distribution €na of Scienion products in China by RayBiotech Inc 2014-08-13
Seventh Sense Biosystems–Novartis: investment, 201408 financing round Series B totalling $16m incl new investor Novartis 2014-08-13
Seventh Sense Biosystems–SEVERAL: investment, 201408 financing round Series B $16m from Siemens + Novartis + LabCorp + Flagship + Polaris 2014-08-13
Seventh Sense Biosystems–Siemens: investment, 201408 financing round Series B totalling $16m incl new investor Siemens Financial Services VC 2014-08-13
Inocard–Uniqure: investment, 201408 acquisition of Inocard GmbH for €1.5m in cash + €1.5m in shares upfront plus milestones + royalties 2014-08-11
Biognosys–ETH Zürich: HRM-MS technology, 201408 license to N-glyco-capture technology invented by Ruedi Aebersold 2014-08-08
Sopat–High-Tech Gründerfonds: investment, 201408 DIVESTMENT sale of shares in Sopat by HTGF to Dr Max Iann Invest GmbH 2014-08-06
Amptek–AMETEK: investment, 201408 acquisition of Amptek Inc 2014-08-05
Prosarix–Evolva: investment, 201408 acquisition in shares with 1.2m Evolva shares upfront + 2m shares milestones 2014-08-04
Santaris Pharma–Roche: investment, 201408 acquisition $250m upfront cash + $200m milestones 2014-08-04
i3 Membrane–DBU: grant, 201408 existent €250k to support developm of steel-based membrane technology 2014-08-01
i3 Membrane–Hamburg (govt): investment, 201408 investment by Innovationsstarter Fonds Hamburg + HTGF 2014-08-01
i3 Membrane–High-Tech Gründerfonds: investment, 201408 investment by HTGF + Innovationsstarter Fonds Hamburg 2014-08-01
Medineering–High-Tech Gründerfonds: investment, 201408 seed financing round from HTGF + Bayern Kapital + Born2Grow + consortium of business angels 2014-08-01
Medineering–SEVERAL: investment, 201408 seed financing round from HTGF + Bayern Kapital + Born2Grow + consortium of business angels 2014-08-01
IBL International–Tecan: investment, 201407 acquisition €29m in cash 2014-07-30
Riboxx–SEVERAL: investment, 201407–201501 crowdfunding €1m via Seedmatch 2014-07-30
Artes Biotechnology–Burnet Institute: malaria vaccine, 201407– collab development funded by PATH Malaria Vaccine Initiative (MVI) 2014-07-29
Artes Biotechnology–Burnet Institute: Metavax VLP technology, 201407 license existent Artes holds international patent rights 2014-07-29
BIA Separations–Showa Denko: investment, 201407 existent Showa Denko is co-owner of BIO Separations GmbH 2014-07-29
Showa Denko–BIA Separations: LC columns, 201407– collab expansion Showa Denko takes over BIA sales in Asia-Pacific region 2014-07-29
Boehringer–Hikma: investment, 201407– acquisition of US generic injectiables business Bedford Laboratories by Hikma from BI 2014-07-28
Boehringer–Zealand Pharma: peptide drug, 201407– collab + ww excl rights for cardio-metabolic disease €295m milestones + research funding + royalties 2014-07-28
Butalco–Lesaffre: investment, 201407 acquisition 2014-07-23
Boehringer–Univ Toronto: drug target discovery, 201407– collab to characterise new drug targets in ubiquitin system 2014-07-22
InflaRx–SEVERAL: investment, 201407 financing round Series B closing of 2nd + last tranche led by bm-t Thüringen 2014-07-17
LTS Lohmann Therapie-Systeme–Hopp Group: investment, 201407– acquisition all remaining shares by existent shareholder Dievini Hopp BioTech Holding 2014-07-17
Metrohm–Waters: chromatography s/w, 201407– collab product integration Empower CDS now can control Metrohm IC systems 2014-07-17
Paion–Pharmascience: investment, 201407 private placement €4m with 1.27m new shares €3.15/share to Pharmasience Intl Ltd 2014-07-17
Biosynthetic Technologies–Evonik: investment, 201407 financing round incl Evonik Venture Capital + BP Ventures 2014-07-16
Immatics–SEVERAL: investment, 201407 financing round Series D 2nd tranche €22m of €34m round Hopp + Strüngmann + Wellington Partners et al 2014-07-16
Siemens–Danaher: investment, 201407– acquisition Siemens Healthcare Diagnostics' Clinical Microbiology Business by Beckman Coulter 2014-07-16
Amcure–Germany (govt): grant, 201407 BMBF subsidy via Spinnovator programme managed by Ascenion 2014-07-15
Amcure–SEVERAL: investment, 201407 financing round Series A €5m led by LBBW Venture Capital GmbH 2014-07-15
Geisinger–Indivumed: tissue bank, 201407– collab to create cancer research biobanks at Geisinger + Indivumed 2014-07-15
Fosun–Miacom Diagnostics: molecular diagnostics, 201407– distribution molecular mulitplex sepsis + pneumonia assays by Fosun Diagnostics in CN + Asia 2014-07-14
Ayoxxa–SEVERAL: investment, 201407 financing round Series B €9m all existing investors + new investors 2014-07-10
International Council of Biotechnology Associations–BIO Deutschland: biotechnology, 201407 BIO Deutschland is founding member of ICBA 2014-07-10
International Council of Biotechnology Associations–EuropaBio: biotechnology, 201407 EuropaBio is founding member of ICBA 2014-07-10
International Council of Biotechnology Associations–Swiss Biotech Association: biotechnology, 201407 SBA is founding member of ICBA 2014-07-10
next pagenext page 1 2 3 ... 25 26 27 ... 55 56 57  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top